MP16-08 REVO-I® SURGICAL ROBOTIC SYSTEM: RESULTS OF KOREAN FDA (KFDA) APPROVED CLINICAL TRIAL

Robotic Cholecystectomy Using the Newly Developed Korean Robotic Surgical System, Revo-i: A Preclinical Experiment in a Porcine Model

One Korean company recently successfully produced a robotic surgical system prototype called Revo-i (MSR-5000). We, therefore, conducted a preclinical study for robotic cholecystectomy using Revo-i, and this is a report of the first case of robotic cholecystectomy performed using the Revo-i system in a preclinical porcine model. Revo-i consists of a surgeon console (MSRC-5000), operation cart (...

Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks

Kinase is one of the most productive classes of established targets, but the majority of approved drugs against kinase were developed only for cancer. Intensive efforts were therefore exerted for releasing its therapeutic potential by discovering new therapeutic area. Kinases in clinical trial could provide great opportunities for treating various diseases. However, no systematic comparison bet...

Laparoscopic stripping of endometriomas: a randomized trial on different surgical techniques. Part I: clinical results.

BACKGROUND Laparoscopic surgery has become the gold-standard treatment for ovarian endometriomas. The objective of this trial was to evaluate different procedures for the laparoscopic excision of ovarian endometriomas with the stripping technique. METHODS Forty-eight patients with ovarian endometrioma were enrolled in two consecutive independent randomized trials. Two different techniques wer...

FDA-Approved Drugs to Treat Schizophrenia.

Robotic surgical system under scrutiny.